|
1
|
Ference BA, Ginsberg HN, Graham I, Ray KK,
Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H,
et al: Low-density lipoproteins cause atherosclerotic
cardiovascular disease. 1. Evidence from genetic, epidemiologic,
and clinical studies. A consensus statement from the European
Atherosclerosis Society Consensus Panel. Eur Heart J. 38:2459–2472.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen LY, Leening MJ, Norby FL, Roetker NS,
Hofman A, Franco OH, Pan W, Polak JF, Witteman JC, Kronmal RA, et
al: Carotid intima-media thickness and arterial stiffness and the
risk of atrial fibrillation: The Atherosclerosis Risk in
Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis
(MESA), and the Rotterdam Study. J Am Heart Assoc. 5:e0029072016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Trpkovic A, Resanovic I, Stanimirovic J,
Radak D, Mousa SA, Cenic-Milosevic D, Jevremovic D and Isenovic ER:
Oxidized low-density lipoprotein as a biomarker of cardiovascular
diseases. Crit Rev Clin Lab Sci. 52:70–85. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weber C and Noels H: Atherosclerosis:
Current pathogenesis and therapeutic options. Nat Med.
17:1410–1422. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mestas J and Ley K: Monocyte-endothelial
cell interactions in the development of atherosclerosis. Trends
Cardiovasc Med. 18:228–232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koroleva IA, Nazarenko MS and Kucher AN:
Role of microRNA in development of instability of atherosclerotic
plaques. Biochemistry (Mosc). 82:1380–1390. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laffont B and Rayner KJ: MicroRNAs in the
pathobiology and therapy of atherosclerosis. Can J Cardiol.
33:313–324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Papageorgiou N, Tslamandris S, Giolis A
and Tousoulis D: MicroRNAs in cardiovascular disease: Perspectives
and reality. Cardiol Rev. 24:110–118. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giral H, Kratzer A and Landmesser U:
MicroRNAs in lipid metabolism and atherosclerosis. Best Pract Res
Clin Endocrinol Metab. 30:665–676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsushita R, Seki N, Chiyomaru T,
Inoguchi S, Ishihara T, Goto Y, Nishikawa R, Mataki H, Tatarano S,
Itesako T, et al: Tumour-suppressive microRNA-144-5p directly
targets CCNE1/2 as potential prognostic markers in bladder cancer.
Br J Cancer. 113:282–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamada Y, Arai T, Kojima S, Sugawara S,
Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T and Seki N:
Regulation of antitumor miR-144-5p targets oncogenes: Direct
regulation of syndecan-3 and its clinical significance. Cancer Sci.
109:2919–2936. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song L, Peng L, Hua S, Li X, Ma L, Jie J,
Chen D, Wang Y and Li D: miR-144-5p Enhances the radiosensitivity
of non-small-cell lung cancer cells via targeting ATF2. BioMed Res
Int. 2018:51094972018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Wang R, Ge Y, Chen D, Wu B and Fang
F: Assessment of microRNA-144-5p and its putative targets in
inflamed gingiva from chronic periodontitis patients. J Periodontal
Res. 54:266–277. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Sundquist K, Hedelius A, Palmér K,
Memon AA and Sundquist J: Circulating microRNA-144-5p is associated
with depressive disorders. Clin Epigenetics. 7:692015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goumans MJ, Liu Z and ten Dijke P:
TGF-beta signaling in vascular biology and dysfunction. Cell Res.
19:116–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bai Y, Zhang Q, Su Y, Pu Z and Li K:
Modulation of the proliferation/apoptosis balance of cascular
smooth muscle cells in atherosclerosis by lncRNA-MEG3 via
regulation of miR-26a/smad1 axis. Int Heart J. 60:444–450. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weng J, Wang C, Zhong W, Li B, Wang Z,
Shao C, Chen Y and Yan J: Activation of CD137 signaling promotes
angiogenesis in atherosclerosis via modulating endothelial
Smad1/5-NFATc1 pathway. J Am Heart Assoc. 6:62017. View Article : Google Scholar
|
|
20
|
Peng YG and Zhang L: Baohuoside-I
suppresses cell proliferation and migration by up-regulating
miR-144 in melanoma. Pharm Biol. 56:43–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mudau M, Genis A, Lochner A and Strijdom
H: Endothelial dysfunction: The early predictor of atherosclerosis.
Cardiovasc J Afr. 23:222–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Li Y and Tang C: The role of
microRNAs in the involvement of vascular smooth muscle cells in the
development of atherosclerosis. Cell Biol Int. 43:1102–1112. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su Y, Yuan J, Zhang F, Lei Q, Zhang T, Li
K, Guo J, Hong Y, Bu G, Lv X, et al: MicroRNA-181a-5p and
microRNA-181a-3p cooperatively restrict vascular inflammation and
atherosclerosis. Cell Death Dis. 10:3652019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li K, Chen ZT and Qin YW: Expression
profiles of microRNA related to atherosclerosis in patients with
OSA. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 33:304–309.
2019.(In Chinese). PubMed/NCBI
|
|
26
|
Wang Z, Zhang J, Zhang S, Yan S, Wang Z,
Wang C and Zhang X: miR-30e and miR-92a are related to
atherosclerosis by targeting ABCA1. Mol Med Rep. 19:3298–3304.
2019.PubMed/NCBI
|
|
27
|
Cheng Y, Zhou M and Zhou W: MicroRNA-30e
regulates TGF-β-mediated NADPH oxidase 4-dependent oxidative stress
by Snai1 in atherosclerosis. Int J Mol Med. 43:1806–1816.
2019.PubMed/NCBI
|
|
28
|
Yang L and Gao C: miR-590 inhibits
endothelial cell apoptosis by inactivating the TLR4/NF-κB pathway
in atherosclerosis. Yonsei Med J. 60:298–307. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fang M, Li Y, Wu Y, Ning Z, Wang X and Li
X: miR-185 silencing promotes the progression of atherosclerosis
via targeting stromal interaction molecule 1. Cell Cycle.
18:682–695. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Biedermann BC: Vascular endothelial cells:
An interesting immunological barrier. Schweiz Med Wochenschr.
129:1712–1716. 1999.(In German). PubMed/NCBI
|
|
31
|
Tian X, Yu C, Shi L, Li D, Chen X, Xia D,
Zhou J, Xu W, Ma C, Gu L, et al: MicroRNA-199a-5p aggravates
primary hypertension by damaging vascular endothelial cells through
inhibition of autophagy and promotion of apoptosis. Exp Ther Med.
16:595–602. 2018.PubMed/NCBI
|
|
32
|
Soufi-Zomorrod M, Hajifathali A, Kouhkan
F, Mehdizadeh M, Rad SM and Soleimani M: MicroRNAs modulating
angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs.
Tumour Biol. 37:9527–9534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu F, Hata A, Baker JC, Doody J, Cárcamo
J, Harland RM and Massagué J: A human Mad protein acting as a
BMP-regulated transcriptional activator. Nature. 381:620–623. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ren YF, Zhang TH, Zhong S, Zhao YT and Lv
YN: miR-144 suppresses proliferation and induces apoptosis of
osteosarcoma cells via direct regulation of mTOR expression. Oncol
Lett. 15:1163–1169. 2018.PubMed/NCBI
|
